Feed/Investors/Tetragon Financial Group

Tetragon Financial Group

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2021-07-27

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$153M

across 1 round

LATEST ROUND

Series C · $153M · 2021-07-27

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Artios Pharma Artios is a clinical-stage oncology company developing new medicines targeting DNA damage response pathways in cancer for patients with limited treatment options.	Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$153M	2021-07-27	[ PART ]